Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Operating Leases (2022 - 2025)

Historic Operating Leases for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $2.4 million.

  • PAVmed's Operating Leases changed N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2024, which is 3900.55% down from last year.
  • Per PAVmed's latest filing, its Operating Leases stood at $2.4 million for Q3 2025.
  • In the past 5 years, PAVmed's Operating Leases registered a high of $6.0 million during Q2 2024, and its lowest value of $2.0 million during Q3 2024.
  • Moreover, its 4-year median value for Operating Leases was $3.0 million (2022), whereas its average is $3.6 million.
  • In the last 5 years, PAVmed's Operating Leases surged by 7443.81% in 2023 and then tumbled by 5840.24% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Operating Leases stood at $3.0 million in 2022, then skyrocketed by 51.49% to $4.5 million in 2023, then crashed by 39.01% to $2.8 million in 2024, then fell by 13.77% to $2.4 million in 2025.
  • Its Operating Leases was $2.4 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.6 million in Q1 2025.